Idiopathic hypereosinophilic syndrome with cutaneous involvement: a comparative review of 32 cases

BMJ Case Rep. 2018 Dec 3;11(1):bcr2018227137. doi: 10.1136/bcr-2018-227137.

Abstract

Although idiopathic hypereosinophilic syndrome (HES) is uncommon, we studied the clinical characteristics of this disorder in patients with cutaneous involvement. We chronicle the case of a patient with diffuse skin rash due to idiopathic HES from our clinical experience. Furthermore, a systematic literature search of the medical databases PubMed and Google Scholar was conducted. A total of 32 cases fulfilled the inclusion criteria. The data on patients' characteristics, epidemiology, clinical features, diagnosis, treatment and outcome were collected and analysed. This review illustrates that physicians should maintain a high index of clinical suspicion for idiopathic HES in patients presenting with dermatological lesions and hypereosinophilia, without an obvious cause. Randomised clinical trials are warranted to outline a generalised and efficient therapeutic approach in these patients. Additionally, this paper highlights the need for population-based studies to delineate the magnitude and scope of this association.

Keywords: dermatology; general practice/family; haematology (incl blood transfusion); medical management; skin.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use*
  • Bone Marrow Examination
  • Diagnosis, Differential
  • Exanthema / etiology
  • Humans
  • Hypereosinophilic Syndrome / complications
  • Hypereosinophilic Syndrome / diagnosis*
  • Hypereosinophilic Syndrome / drug therapy
  • Infusions, Intravenous
  • Male
  • Middle Aged

Substances

  • Adrenal Cortex Hormones